{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:55:17Z","timestamp":1791424517201,"version":"4.3.3"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key Basic Research Program of China","award":["2009CB930300"],"award-info":[{"award-number":["2009CB930300"]}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Commission of Education","doi-asserted-by":"crossref","award":["10SG05"],"award-info":[{"award-number":["10SG05"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ijpharm.2012.10.025","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T12:01:40Z","timestamp":1350993700000},"page":"693-700","source":"Crossref","is-referenced-by-count":163,"title":["Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media"],"prefix":"10.1016","volume":"441","author":[{"given":"Shunwen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongning","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.10.025_bib0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejpb.2008.09.004","article-title":"Solubilisation of dipalmitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile salt","volume":"71","author":"Andrieux","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0010","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1023\/A:1018928613837","article-title":"Stability of acyl derivatives of insulin in the small intestine: relative importance of insulin association characteristics in aqueous solution","volume":"11","author":"Asada","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejps.2009.10.016","article-title":"New insights into the mode of action of ultradeformable vesicles using calcein as hydrophilic fluorescent marker","volume":"39","author":"Bahia","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0168-3659(96)01459-9","article-title":"Polymerized liposomes as potential oral vaccine carriers: stability and bioavailability","volume":"42","author":"Chen","year":"1996","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2009.04.022","article-title":"Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt","volume":"376","author":"Chen","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0378-5173(87)90011-1","article-title":"Gastrointestinal uptake of liposomes. I. In vitro and in situ studies","volume":"37","author":"Chiang","year":"1987","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0035","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/S0264-410X(00)00537-5","article-title":"Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)","volume":"19","author":"Conacher","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2010.11.034","article-title":"Gastrointestinal contents in fasted state and post-lipid ingestion: in vivo measurements and in vitro models for studying oral drug delivery","volume":"151","author":"Di Maio","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/psc.66","article-title":"Current concepts in intestinal peptide absorption","volume":"2","author":"Fricker","year":"1996","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrd1067","article-title":"Challenges for the oral delivery of macromolecules","volume":"2","author":"Goldberg","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2004.12.022","article-title":"Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study","volume":"293","author":"Gupta","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(97)00237-8","article-title":"Oral delivery of insulin by using surface coating liposomes: improvement of stability of insulin in GI tract","volume":"157","author":"Iwanaga","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0065","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0928-0987(99)00064-0","article-title":"Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition","volume":"9","author":"Kokkona","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ymeth.2005.11.002","article-title":"Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity","volume":"38","author":"Mann","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.60.1.0008","article-title":"Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in vivo experiments","volume":"60","author":"McConnell","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0085","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.colsurfb.2007.09.003","article-title":"Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels","volume":"61","author":"Mourtas","year":"2008","journal-title":"Colloid. Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0090","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/mp100149j","article-title":"Physiological parameters for oral delivery and in vitro testing","volume":"7","author":"Mudie","year":"2010","journal-title":"Mol. Pharmaceut."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0095","doi-asserted-by":"crossref","first-page":"G1151","DOI":"10.1152\/ajpgi.1997.272.5.G1151","article-title":"Characterization of proteases and protease inhibitors in the rat stomach","volume":"272","author":"Nagy","year":"1997","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0100","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1023\/A:1018959511323","article-title":"Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data","volume":"16","author":"Nicolaides","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0105","first-page":"1155","article-title":"Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation","volume":"6","author":"Niu","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2012.02.009","article-title":"Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose","volume":"81","author":"Niu","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.reactfunctpolym.2010.10.002","article-title":"Oral protein delivery: current status and future prospect","volume":"71","author":"Park","year":"2011","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0120","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2011.05.066","article-title":"Oral peptide delivery by tetraether lipid liposomes","volume":"415","author":"Parmentier","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0125","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijpharm.2010.12.005","article-title":"Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids","volume":"405","author":"Parmentier","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nano.2006.04.009","article-title":"Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems","volume":"2","author":"Pinto Reis","year":"2006","journal-title":"Nanomed. Nanotech. Biol. Med."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0135","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0005-2760(80)90131-9","article-title":"The stability of liposomes in vitro to pH, bile salts and pancreatic lipase","volume":"620","author":"Rowland","year":"1980","journal-title":"Biochim. Biophy. Acta"},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000198984","article-title":"Studies on the mechanism of bile salt-induced liposomal membrane damage","volume":"28","author":"Schubert","year":"1983","journal-title":"Digestion"},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0145","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S1359-6446(01)02010-4","article-title":"Bilosomes: the answer to oral vaccine delivery?","volume":"6","author":"Senior","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.18433\/J3K01M","article-title":"Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes)","volume":"11","author":"Shukla","year":"2008","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0155","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jbiotec.2010.08.255","article-title":"Nano-bilosomes as potential vaccine delivery system for effective combined oral immunization against tetanus and hepatitis B","volume":"150","author":"Shukla","year":"2010","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2009.10.027","article-title":"M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes","volume":"385","author":"Shukla","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijpharm.2004.03.014","article-title":"Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization","volume":"278","author":"Singh","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0170","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jconrel.2005.05.016","article-title":"Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts","volume":"106","author":"Song","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/10717540490280769","article-title":"Stability of liposomal formulations in physiological conditions for oral drug delivery","volume":"11","author":"Taira","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2005.06.028","article-title":"Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs","volume":"303","author":"Takeuchi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat. Rev. Drug Dis."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0190","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","article-title":"Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds","volume":"60","author":"Vertzoni","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0195","doi-asserted-by":"crossref","first-page":"591325","DOI":"10.1155\/2011\/591325","article-title":"Liposome technology for industrial purposes","volume":"2011","author":"Wagner","year":"2011","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2008.11.013","article-title":"Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation","volume":"370","author":"Werle","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jconrel.2006.03.005","article-title":"Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids","volume":"112","author":"Yamagata","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.10.025_bib0210","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1023\/A:1018968611962","article-title":"Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats","volume":"11","author":"Yamamoto","year":"1994","journal-title":"Pharm. Res."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312009659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312009659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T22:48:04Z","timestamp":1562280484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312009659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0378517312009659"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.10.025","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}